Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under IMMUNIC, INC. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Duane Nash, Director (Form 8-K filed 2026-09-11). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Commodore Capital LP (filed 2026-08-14).
Who is behind it
IMMUNIC, INC.: incorporated in Delaware; business address in New York, X1; industry Pharmaceutical Preparations (Form D, 2026-09-11).
Officers and directors, each with the role and the filing that names them:
- DANIEL VITT: Executive Officer, Director (Form D, 2026-03-04)
- SIMONA SKERJANEC: Director (Form D, 2026-03-04)
- DUANE NASH: Director (Form D, 2026-03-04)
- TAMAR HOWSON: Director (Form D, 2026-03-04)
- JOERG NEERMAN: Director (Form D, 2026-03-04)
- RICHARD RUDICK: Director (Form D, 2026-03-04)
- ANDREAS MUEHLER: Executive Officer (Form D, 2026-03-04)
- PATRICK WALSH: Executive Officer (Form D, 2026-03-04)
- THORVALD NAGEL: Director (Form D, 2026-03-04)
- HELLA KOHLHOF: Executive Officer (Form D, 2026-03-04)
- GLENN WHALEY: Executive Officer (Form D, 2026-03-04)
- INDERPAL SINGH: Executive Officer (Form D, 2026-03-04)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Commodore Capital LP | 9.9% |
| Schedule 13G/A, 2026-08-14 | Nantahala Capital Management, LLC | 7.47% |
| Schedule 13G, 2026-08-14 | Orbimed Advisors LLC | 5.3% |
| Schedule 13G/A, 2026-08-13 | Soleus Capital Master Fund, L.P. | 4.9% |
| Schedule 13G/A, 2026-08-06 | Millennium Management LLC | 7% |
| Schedule 13G, 2026-08-04 | Laurion Capital Management LP | 6.06% |
| Schedule 13G/A, 2026-07-16 | Aberdeen Group PLC | 6.05% |
| Schedule 13G/A, 2026-05-15 | 683 Capital Management, LLC | 3.4% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-09-11 | Duane Nash | Director | departed | |
| Form 8-K, 2026-08-11 | Elena Ridloff | Director | appointed | |
| Form 8-K, 2026-07-06 | Tamar Howson | Director | departed | |
| Form 8-K, 2026-05-27 | Erik Lundgren | Chief Executive Officer | appointed | |
| Form 8-K, 2026-05-19 | Michael W. Bonney | Chair of the Board | appointed | |
| Form 8-K, 2026-04-28 | Michael A. Panzara | Chief Medical Officer | appointed | 2026-04-24 |
| Form 8-K, 2026-04-28 | Andreas Muehler | Chief Medical Officer | departed | |
| Form 8-K, 2026-04-28 | Andreas Muehler | appointed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-03-04 | $200M | $200M |
| Form D, 2024-01-19 | $80M | $240M |
| Form D, 2022-10-18 | $60M | $60M |
Related pages
Funding and filing historyLeadership changes5%+ holdersCourt record
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/immunic-incLast updated 2026-10-18
Primary record: Schedule 13G/A, 2026-08-14 · Form D, 2026-03-04 · Form 8-K, 2026-09-11 · Form 8-K, 2026-08-11
Who owns IMMUNIC, INC.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/immunic-inc